Why this ASX biotech stock is soaring 30% today
ASX biotech stock Neuren Pharmaceuticals Ltd (ASX: NEU) is flying on Monday. The ASX biotech stock jumped around 30% to $15.92 in morning trade after announcing a major regulatory breakthrough in Europe for its lead drug, DAYBUE. Despite today's rally …